As a continuation of CSR practice, Orion Pharma Ltd. introduces Enliven Patients Assistance Program (EPAP). EPAP is an endeavor to provide Enliven capsule (Imatinib 100 mg) at subsidised price or in some cases at free of cost for the underprivileged blood cancer patients in Bangladesh. Founded in 2004, EPAP has served more than one hundred CML (Chronic Myeloid Leukemia) patients so far with a vow of maintaining this further.